Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Tohoku J Exp Med ; 256(1): 73-84, 2022 01.
Article in English | MEDLINE | ID: mdl-35082185

ABSTRACT

Suicide is an important public health issue for adolescents. To investigate the risk and protective factors for adolescent suicide, a cross-sectional questionnaire-based survey was conducted at a junior high school (n = 379) in Japan in 2018. After obtaining survey data, we conducted univariate and logistic regression analyses to test for associations between suicidal ideation and several factors, including worries (i.e., about school life, interpersonal relationships at school, family life, interpersonal relationships at home, and academic performance), perceived support from school staff and family members, and social capital. In this context, the existence of trustful relationships between classmates was used as indicators of social capital. The results showed that the prevalence of suicidal ideation was 10.5%. The risk of suicidal ideation was increased by worries about 1) interpersonal relationships at school, 2) interpersonal relationships at home, and 3) academic performance, but was decreased by social support from family members and trusting relationships. Further, the rate of suicidal ideation was higher among students who expressed all these three worries when compared to those who expressed two or fewer worries. In addition, looking at students who expressed all these three worries simultaneously, the rate of suicidal ideation was higher among those with lower levels of support from family members and fewer trustful relationships. Our results suggest that the prevention of adolescent suicide should include strategies for reducing worries about interpersonal relationships at school/home and academic performance while finding ways to enhance family support and classmate social capital.


Subject(s)
Academic Performance , Social Capital , Adolescent , Cross-Sectional Studies , Humans , Japan , Risk Factors , Social Support , Students , Suicidal Ideation
2.
Eur J Pediatr ; 162(10): 697-702, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12898240

ABSTRACT

UNLABELLED: We studied the clinical and biochemical factors associated with surfactant dysfunction and factors affecting the responsiveness to exogenous surfactant among 27 neonates with haemorrhagic pulmonary oedema (HPE). HPE was defined as the presence of a large amount of blood-stained lung effluent and respiratory failure which was difficult to differentiate from respiratory distress syndrome. Among the neonates, 33% had very low birth weight, 96% were preterm, 70% were delivered by caesarean section, and 44% had delivery room intubation. The onset of HPE was at 1.5+/-0.1 h (mean +/- SEM) after birth. In 26 cases, surfactant was administered at 3.0+/-1.3 h after the onset of HPE. The concentrations of surfactant protein A (SP-A), disaturated phosphatidylcholine (DSPC), and albumin in the epithelial lining fluid were determined using the first lung effluent from the patients. The level of inhibitory activity against pulmonary surfactant in the effluent was determined in vitro. Surfactant inhibitory activity was associated with lower birth weight, earlier gestational age, delivery room intubation, earlier onset of HPE, and lower SP-A or DSPC concentration. A good response to exogenous surfactant, which was defined as ventilatory index <0.047 at 1 h after surfactant administration, was seen in 82% of cases, and was associated with lower serum albumin, lower birth weight, and earlier gestational age. Cases with higher DSPC concentration prior to surfactant administration and shorter interval between the onset of HPE and surfactant administration showed an immediate response to surfactant, followed by no increase in ventilatory index for 24 h after surfactant administration. CONCLUSION: exogenous surfactant appeared to be a useful adjunctive therapy for overcoming surfactant inhibition and normalising the respiratory status of infants with haemorraghic pulmonary oedema. Surfactant treatment for this indication awaits further investigations including a randomised controlled study.


Subject(s)
Biological Products/therapeutic use , Hemothorax/complications , Pulmonary Edema/complications , Pulmonary Surfactants/therapeutic use , Respiratory Distress Syndrome, Newborn/drug therapy , Albumins/analysis , Female , Humans , Infant, Newborn , Male , Phosphatidylcholines/analysis , Regression Analysis , Respiratory Distress Syndrome, Newborn/etiology , Retrospective Studies
3.
Pediatr Int ; 44(4): 363-7, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12139558

ABSTRACT

BACKGROUND: The aim of the study was to observe the inflammatory changes during the therapy for symptomatic patent ductus arteriosus (sPDA). METHODS: We investigated biochemically the sample of the tracheobroncheal aspirates (TA) from 11 intubated premature infants. Three i.v. doses of indomethacin (0.2 mg/kg)were administered with 24-h intervals. The samples were divided into two groups, the effective occasions (n = 10)and non-effective occasions (n = 6). The amounts of myeloperoxidase (MPO), soluble L-selectin (sL-selectin)in TA, and the polymorphonuclear leukocytes (PMN) of peripheral blood stream and TA were analyzed before and after treatment ofsPDA with indomethacin. RESULTS: In effective occasions, there were significant decreases of peripheral PMN and MPO and PMN in TA. However, this group had a significant increase of sL-selectin. In non-effective occasions, five out of six samples had decreases of MPO and PMNin TA, but not significantly. In contrast, there was a significant decrease of sL-selectin. CONCLUSION: These data suggested that anti-inflammatory change after closure of sPDA may be caused by not only indomethacin itself, but also ductal closure itself. However, further study is necessary to clarify the relationship between the closure of the ductus itself and anti-inflammatory action in the lung.


Subject(s)
Ductus Arteriosus, Patent/complications , Infant, Premature, Diseases/etiology , Pneumonia/etiology , Humans , Infant, Newborn , L-Selectin/analysis , Leukocyte Count , Neutrophils , Peroxidase/blood
4.
Eur J Pediatr ; 161(4): 196-201, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12014385

ABSTRACT

UNLABELLED: Risk factors of renal involvement and significant proteinuria in patients with Henoch-Schönlein purpura (HSP) were retrospectively evaluated by univariate and multivariate analyses. The analysis was performed in 134 patients with HSP. Renal involvement was found in 65 patients (49%) and 97% of the renal involvement was found within 3 months of disease onset. Moderate or severe proteinuria was recognised in 25 patients. A univariate analysis revealed that an age of more than 4 years at the onset, severe abdominal pain with gastrointestinal bleeding, persistent purpura over a month, coagulation factor XIII activity < 80%, and treatment with factor XIII concentrate were associated with developing renal involvement. A multivariate analysis showed that severe abdominal symptoms, an age of more than 4 years, and persistent purpura increased the risk of renal involvement. Risk factors of moderate or severe proteinuria were also examined. The risk factors in a univariate analysis were severe abdominal symptoms, persistent purpura, decreased factor XIII activity, treatment with steroids, and treatment with factor XIII concentrate. Of those, persistent purpura, treatment with factor XIII concentrate, and factor XIII activity < 80% were associated with significant proteinuria in a multivariate analysis. Among the patients with severe abdominal symptoms, factor XIII activity was significantly decreased in patients with significant proteinuria compared to other patients without significant proteinuria. CONCLUSION: Long-term prognosis of Henoch-Schönlein purpura is dependent on the severity of renal involvement. In those patients who have the risk factors of renal involvement, especially significant proteinuria, close attention should be paid to a urinalysis for at least 3 months from the onset of the disease.


Subject(s)
IgA Vasculitis/complications , Kidney Diseases/etiology , Child, Preschool , Factor XIII , Female , Humans , IgA Vasculitis/epidemiology , IgA Vasculitis/urine , Infant , Infant, Newborn , Male , Multivariate Analysis , Prognosis , Proteinuria/etiology , Proteinuria/urine , Risk Factors
5.
Biol Neonate ; 81(2): 95-8, 2002.
Article in English | MEDLINE | ID: mdl-11844877

ABSTRACT

The expression of adherent leukocyte surface molecules, L-selectin (CD62L), and Mac-1 (CD11b/CD18) in peripheral blood polymorphonuclear leukocytes (PMNs) was studied in 48 neonates and 24 healthy adults using fluorescence flow cytometry. L-selectin expression was decreased significantly in neonates, especially those with severe asphyxia (n = 10) compared with adults. Mac-1 expression was significantly increased in neonates compared with adults, but did not differ between 24 normal neonates, 14 neonates with mild asphyxia, and 10 neonates with severe asphyxia. These results suggest that the magnitude of the decrease in L-selectin expression reflects the severity of asphyxia in neonates.


Subject(s)
Asphyxia Neonatorum/blood , L-Selectin/biosynthesis , Neutrophils/metabolism , Adult , Flow Cytometry , Humans , Infant, Newborn , Macrophage-1 Antigen/biosynthesis , Middle Aged , Statistics, Nonparametric
6.
Eur J Pediatr ; 161(1): 31-6, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11808878

ABSTRACT

UNLABELLED: The interactions between pulmonary surfactant and meconium have been previously reported, however, no prior study has paid attention to the effect of meconium on the extracellular surfactant metabolism. We studied the effect of meconium on the rate of surfactant subtype conversion from surface-active large surfactant aggregates to inactive small surfactant aggregates using the in vitro surface area cycling method. Human meconium was added to a suspension of large surfactant aggregates isolated from swine lung lavage fluid and the mixture was cycled in a capped polystyrene tube at 37 degrees C. The conversion rate from large to small surfactant aggregates was dependent upon the amount of meconium added. By sufficiently increasing the surfactant concentration, meconium could not significantly affect the surfactant subtype conversion. The conversion rate was temperature-dependent and was slower at 4 degrees C. Heat treatment of meconium diminished the rate of conversion. The potent effect of meconium on surfactant subtype conversion appears to be related to an enzymatic protein containing a serine active site, since the conversion occurred at 37 degrees C and not at lower temperatures and the conversion was blocked in the presence of diisopropyl fluorophosphate. CONCLUSION: Our study suggests that meconium can accelerate surfactant subtype conversion. We believe that the increased rate of conversion caused by meconium is a new mechanism for surfactant inactivation that could occur with lung injuries associated with meconium aspiration syndrome.


Subject(s)
Meconium/metabolism , Pulmonary Surfactants/metabolism , Animals , Humans , In Vitro Techniques , Infant, Newborn , Pulmonary Surfactants/chemistry , Swine , Time Factors
7.
J Med Virol ; 66(1): 28-33, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11748655

ABSTRACT

The occurrence of acute hepatitis after failure of immunoprophylaxis in cases of mother-to-infant transmission of hepatitis B virus (HBV) is uncommon. Because immunoprophylaxis failure is caused by the emergence of an "a" determinant escape mutant, the infants usually become HBV carriers. To evaluate whether mutations in the S gene coding for the surface protein that contains the "a" determinant are associated with acute hepatitis after immunoprophylaxis failure, HBV DNA of an infant in with acute hepatitis developed with seroconversion to anti-HBs antibodies at 12 months of age despite administration of anti-hepatitis B immunoglobulin and hepatitis B vaccine was analyzed. The S gene from HBV DNA isolated from the serum of the infant at 12, 19, and 27 months of age was cloned and sequenced. Mutations affecting amino acid residues in the first loop within the "a" determinant (codons 124-147) were found at 12 months of age. Moreover, a novel deletion mutant, with a 1-bp deletion at nucleotide 449 of the S gene, was found at 19 and 27 months of age. This deletion resulted in a frame shift and it introduced a stop codon (TAG) at codon 176. Because the open reading frame of the S gene is completely overlapped by the polymerase gene, mutations in the S gene may affect the polymerase gene. Based on this case, this study suggests that the observed frame-shift mutation in the S gene might affect the polymerase protein and induce prompt suppression of viral replication.


Subject(s)
HIV Antibodies/blood , Hepatitis B Vaccines/administration & dosage , Hepatitis B virus/immunology , Hepatitis B/prevention & control , Hepatitis B/therapy , Immunoglobulins/administration & dosage , Infectious Disease Transmission, Vertical , Acute Disease , Amino Acid Sequence , Base Sequence , DNA, Viral/blood , Female , Gene Deletion , HIV Antibodies/administration & dosage , HIV Antibodies/immunology , Hepatitis B/transmission , Hepatitis B/virology , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/immunology , Hepatitis B virus/genetics , Humans , Immunoglobulins/immunology , Infant , Male , Molecular Sequence Data , Sequence Analysis, DNA , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...